Full text
Earnings transcript
Read the complete earnings call transcript.
PATH
UiPath Inc.
$12.85
-0.86
(-6.27%)
| Exchange: | NYSE |
| Market Cap: | 6.697B |
| Shares Outstanding: | 519.154M |
Delayed data
About The Company
| Sector: | TechnologyView sector performance | |||||
| Industry: | Software – InfrastructureView industry performance | |||||
| CEO: | Daniel Solomon Dines | |||||
| Full Time Employees: | 3981 | |||||
| Address: |
| |||||
| Website: | https://www.uipath.com |
UiPath Inc. delivers a comprehensive automation ecosystem, specializing in Robotic Process Automation (RPA) solutions, with a significant presence in the United States, Romania, and Japan. The company’s integrated software suite empowers organizations to design, administer, execute, interact with, evaluate, and oversee their automation initiatives. This robust platform seamlessly blends artificial intelligence with features such as desktop activity recording and in-depth analysis of both human actions and system logs. Through intuitive visualization tools within a centralized portal, users can effectively discover, analyze, and identify processes ripe for automation. It provides low-code development environments, enabling personnel across an organization to create both human-assisted and fully autonomous automations without needing prior programming knowledge. These automation bots can be deployed for interactive use or run independently in the background, leveraging native connectors for integration with common line-of-business applications. UiPath also offers centralized tools for managing, testing, and deploying automations and machine learning models enterprise-wide, and supports the orchestration of complex, long-running processes that coordinate work between robots and humans. Moreover, the platform allows users to track, measure, and forecast automation performance, assisting businesses in ensuring compliance with industry standards. Beyond its core technology, the company provides essential maintenance and support services, along with professional services like training and implementation to facilitate smooth platform adoption. UiPath’s diverse clientele includes entities in banking, healthcare, financial services, and government. Founded in 2005, UiPath Inc. maintains its headquarters in New York, New York.
Click to read more…
Revenue Segmentation
PATH full analysis
Hey everyone, welcome back to MarketSnap. UiPath has been one of the most beaten-down names in enterprise software, sitting around eleven bucks a share after a brutal multi-year slide — and yet the company just posted its first profitable year, with million-dollar customers up twenty-one percent. So before anyone panic-sells or blindly buys the dip, we're running PATH through our fair value model to see where the numbers actually land. Discount or trap? Let's get into it. So here's the…
EPS
Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.
Earnings Call
AI summary
Key takeaways
Short, structured highlights from the call so you can focus on what matters.
Log in to continue
Log in to read the full transcript and AI-generated earnings summaries.
Login — it's freeIncome Statement
| Year | 2024 | 2025 | 2026 |
|---|---|---|---|
| Revenue | 1,308,072 | 1,429,664 | 1,610,572 |
| Gross Profit | 1,112,148 | 1,182,722 | 1,336,440 |
| EBITDA | -53,218 | -60,868 | 117,597 |
| Operating Income | -164,720 | -162,569 | 60,955 |
| Net Income | -89,883 | -73,694 | 282,330 |
(* All numbers are in thousands)
Balance Sheet
| Year | 2024 | 2025 | 2026 |
|---|---|---|---|
| Total Assets | 2,954,758 | 2,865,270 | 3,179,200 |
| Total Liabilities | 938,644 | 1,019,508 | 1,096,613 |
| Total Stockholders Equity | 2,016,114 | 1,845,762 | 2,082,587 |
| Total Debt | 67,070 | 77,817 | 70,940 |
| Cash and Cash Equivalents | 1,061,678 | 879,196 | 871,157 |
(* All numbers are in thousands)
Cash Flow Statement
| Year | 2024 | 2025 | 2026 |
|---|---|---|---|
| Operating Cash Flow | 299,082 | 320,565 | 371,208 |
| Capital Expenditure | -7,342 | -14,923 | -19,048 |
| Free Cash Flow | 291,740 | 305,642 | 352,160 |
| Net Income | -89,883 | -73,694 | 282,330 |
| Net Change in Cash | -340,003 | -182,482 | -8,039 |
(* All numbers are in thousands)
Analyst Estimates
| Fiscal Year | 2029 | Research Access | Research Access | Research Access | Research Access |
|---|---|---|---|---|---|
| Estimated Revenue (Low) | 2,036,522.693 | Research Access | Research Access | Research Access | Research Access |
| Estimated Revenue (High) | 2,143,556.846 | Research Access | Research Access | Research Access | Research Access |
| Estimated Revenue (Avg) | 2,093,233.028 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (Low) | 560,994.829 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (High) | 965,874.088 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (Avg) | 756,206.526 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (Low) | 426,472.819 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (High) | 746,327.434 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (Avg) | 580,690.060 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (Low) | 1,588,816.324 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (High) | 1,672,320.235 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (Avg) | 1,633,059.537 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (Avg) | 1.050 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (High) | 1.370 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (Low) | 0.780 | Research Access | Research Access | Research Access | Research Access |
| Number of Analysts (Estimated Revenue) | 8 | Research Access | Research Access | Research Access | Research Access |
| Number of Analysts (Estimated EPS) | 4 | Research Access | Research Access | Research Access | Research Access |
Log in to continue
Log in and subscribe to Full Access to see up to 5 years of analyst estimates.
Login — it's free(* All numbers are in thousands)
Current Key Metrics
Log in to continue
Log in to see all key valuation metrics and ratios for this symbol.
Login — it's freeForward P/E Ratios
Log in to continue
Log in with Full Access for forward P/E high/low estimates and the full multi-year table.
Login — it's freeSWOT Analysis
Strengths (preview)
- Solid Liquidity Position: The balance sheet reflects a strong current ratio and quick ratio, indicating the company has ample short-term assets to cover liabilities. This provides a buffer against operational volatility and funds ongoing R&D without immediate reliance on external debt.
- Positive Free Cash Flow Generation: Despite GAAP net losses, the company demonstrates positive free cash flow (FCF) and a healthy FCF yield. This indicates the business model is capable of generating cash, which is critical for funding innovation and potential share buybacks without diluting shareholders.
- High Gross Margins: The gross profit margin remains robust (typical for enterprise software), showcasing the scalability of the software product and the value customers place on automation solutions. This margin provides significant room to absorb operational costs as the company scales.
Log in with Research Access for Weaknesses, Opportunities, Threats, and the complete SWOT.
At what price to buy it? -
Intrinsic Value Calculator
Based on current fundamentals and analyst forecasts, MarketSnap estimates PATH intrinsic value between $15.10 – $16.64 per share. This depends on revenue growth, margins, and discount rate.
This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.
Common questions about PATH valuation
Is UiPath Inc. (PATH) overvalued or undervalued right now?
MarketSnap estimates intrinsic value for UiPath Inc. (PATH) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.
Is PATH a buy, hold, or sell for long-term investors?
MarketSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether PATH trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.
What is PATH’s P/E ratio?
You can see PATH’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.
How is intrinsic value calculated for PATH?
MarketSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MarketSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.
Is PATH a good long-term investment?
Whether PATH fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MarketSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.
PATH
1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.
Daily snapshot
-6.27
Trading Metrics:
| Open: | 13.84 | Previous Close: | 13.71 | |
| Day Low: | 12.73 | Day High: | 14 | |
| Year Low: | 9.2 | Year High: | 19.84 | |
| Price Avg 50: | 14.71 | Price Avg 200: | 12.54 | |
| Volume: | 29.285M | Average Volume: | 61.544M |
Log in to continue
Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.
Login — it's free
